Bath & Body Works (BBWI) has experienced a significant number of swings in its stock price, due to various factors including adjusted price targets, earnings reports, and robust analytical coverage. For instance,
Morgan Stanley reduced its price target for BBWI to $43.00, eliciting a negative impact on the stock's price. However, there are
positive fluctuations as well, as in the case when BBWI's stock soared nearly 10% following
Q4 Earnings that outperformed estimates, in addition to speculation about future performance, leading to more investments. Conversely, a potential
60% drop in BBWI's stock was predicted, causing unease among investors. Reports indicate BBWI shares facing selling pressure from firms such as
Cadian Capital Management LP and
Northern Trust Corp, while they also have been bought by entities like
Algert Global LLC and
AQR Capital Management LLC. Despite daunting hurdles like a
CEO's medical leave and concerns over tariffs, the firm managed to post a strong
Q4 result alongside affirming 2025 financial guidance. Future investor optimism for BBWI may lie in top-line growth projections,
Disney collaborations, and new product launches.
Bath Body Works BBWI News Analytics from Wed, 28 Aug 2024 07:00:00 GMT to Sat, 10 May 2025 21:14:24 GMT -
Rating 3
- Innovation 0
- Information 8
- Rumor -5
